Adrenaline Aguettant 1:10,000

Država: Nova Zelandija

Jezik: angleščina

Source: Medsafe (Medicines Safety Authority)

Aktivna sestavina:

Adrenaline acid tartrate 1.1819 mg/mL equivalent to adrenaline 1 mg;  

Dostopno od:

Juno Pharmaceuticals NZ Limited

Odmerek:

1 mg/10mL

Farmacevtska oblika:

Solution for injection

Sestava:

Active: Adrenaline acid tartrate 1.1819 mg/mL equivalent to adrenaline 1 mg   Excipient: Hydrochloric acid Sodium hydroxide Water for injection

Tip zastaranja:

Restricted

Terapevtske indikacije:

Adjunctive use in the management of cardiac arrest, and anaphylactic shock resulting from reactions to drugs, animal serums, insect stings and other allergens.

Povzetek izdelek:

Package - Contents - Shelf Life: Syringe, plastic, Prefilled PPE with chlorobutyl stopper in blister in aluminium overwrap with oxygen absorber - 1 dose units - 18 months from date of manufacture stored at or below 25°C protect from light - Syringe, plastic, Prefilled PPE with chlorobutyl stopper in blister in aluminium overwrap with oxygen absorber - 10 dose units - 18 months from date of manufacture stored at or below 25°C protect from light

Datum dovoljenje:

2020-06-04

Lastnosti izdelka

NEW ZEALAND DATA SHEET
1.
PRODUCT NAME
Adrenaline Aguettant 1:10000
Solution for injection, 1:10,000 (1 mg in 10 ml).
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Adrenaline Aguettant 1:10,000 is a sterile solution of adrenaline acid
tartrate in water containing
adrenaline acid tartrate 0.1 mg/mL, and sodium chloride 9 mg/ml. The
solution contains no
antimicrobial preservatives. The pH of the solution is between 3.0 and
4.0.
Each 10 mL syringe contains 1.819 mg of adrenaline acid tartrate
(equivalent to 1 mg adrenaline).
Each 1 mL of Adrenaline Aguettant contains 0.1819 mg of adrenaline
acid tartrate (equivalent to 0.1
mg adrenaline).
For full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Adrenaline Aguettant 1:10,000 is a sterile solution for injection
presented in a pre-filled polypropylene
syringe.
Adrenaline Aguettant 1:10,000 is a sterile solution for injection.
Adrenaline Aguettant is a clear solution
presented in a pre-filled polypropylene syringe. The pH of the
solution is between 3.0 and 4.0.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Adjunctive use in the management of cardiac arrest, and anaphylactic
shock resulting from
reactions to drugs, animal serums, insect stings and other allergens.
4.2
DOSE AND METHOD OF ADMINISTRATION
Do not use if the injection is brown or contains a precipitate.
Adrenaline is given by subcutaneous or intramuscular injection. In
extreme emergencies, where
a more rapid effect is required, adrenaline may be given as a dilute
solution (1 in 10,000 or 1
in 100,000) by slow intravenous injection or by slow intravenous
infusion.
ADULTS
In cardiopulmonary resuscitation the initial dose is 1 mg (10 mL of
1:10,000) delivered
intravenously, preferably through a central line, and repeated as
often as every 2 to 3 minutes
during CPR for up to an hour. Depending on the arrhythmia the dose may
in increased after
three injections of 1 mg to 5 mg or 100 µg/kg bodyweight.
Further bolus doses or continuous infusion may be required to maintain
an adequate blood
pressure a